entity

MAPK14/PRMT1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MAPK14/PRMT1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming

Outgoing (1)

TargetRelationTypeStr
neurodegenerationpromoted: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methydisease0.61

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph 0.615 neurodegeneration What is the therapeutic window between i

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the therapeutic window between insufficient and toxic levels of TDP-43 a

neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.615

Related Papers (3)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine meth [PMID:39817908] Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan Cell Rep 2025 0
Identification of energy metabolism-related biomarkers for risk prediction of he [PMID:36304554] Chen H, Jiang R, Huang W, Chen K, Zeng R Front Cardiovasc Med 2022 0
Calcium-dependent methylation by PRMT1 promotes erythroid differentiation throug [PMID:31541584] Liu MY, Hua WK, Chiou YY, Chen CJ, Yao C FEBS Lett 2020 0